- Home
- AXNX
AXNX
Axonics Inc.
as 10-04-2024 4:00pm EST
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 3.5B | IPO Year: | N/A |
| Target Price: | $70.67 | AVG Volume (30 days): | 340.6K |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $48.30 - $69.91 | Next Earning Date: | 10-28-2024 |
| Revenue: | $408,809,000 | Revenue Growth: | 27.81% |
| Revenue Growth (this year): | 25.48% | Revenue Growth (next year): | 19.56% |
Latest Axonics Inc. News
AXNX Breaking Stock News: Dive into AXNX Ticker-Specific Updates for Smart Investing
Business Wire
9 days ago
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Business Wire
17 days ago
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Zacks
2 months ago
Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates
Associated Press Finance
2 months ago
Axonics: Q2 Earnings Snapshot
Business Wire
2 months ago
Axonics Reports Second Quarter 2024 Financial Results
Yahoo Finance Video
4 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
4 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
4 months ago
California seeks company profits in Big Oil climate lawsuit
Compare AXNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AXNX Axonics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.